[1] King TD, Suto MJ, Li Y. The Wnt/beta-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer[J]. J Cell Biochem, 2012, 113(1): 13-18.  doi: 10.1002/jcb.23350
[2] 于金明.放射治疗在乳腺癌治疗中的应用[J].中国实用外科杂志, 2003, 23(10): 582-584.  doi: 10.3321/j.issn:1005-2208.2003.10.005
[3] Chien AJ, Moon RT. WNTS and WNT receptors as therapeutic tools and targets in human disease processes[J]. Front Biosci, 2007, 12: 448-457.  doi: 10.2741/2074
[4] Liu W, Xing F, Iiizumi-Gairani M, et al. N-myc downstream regulated gene 1 modulates Wnt-beta-catenin signalling and pleiotropically suppresses metastasis[J]. EMBO Mol Med, 2012, 4(2): 93-108.  doi: 10.1002/emmm.201100190
[5] Lee MA, Kim WK, Park HJ, et al. Anti-proliferative activity of hydnocarpin, a natural lignan, is associated with the suppression of Wnt/beta-catenin signaling pathway in colon cancer cells[J]. Bioorg Med Chem Lett, 2013, 23(20): 5511-5514.  doi: 10.1016/j.bmcl.2013.08.065
[6] Geyer FC, Lacroix-Triki M, Savage K, et al. β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation[J]. Mod Pathol, 2011, 24(2): 209-231.  doi: 10.1038/modpathol.2010.205
[7] Polakis P. The many ways of Wnt in cancer[J]. Curr Opin Genet Dev, 2007, 17(1): 45-51.  doi: 10.1016/j.gde.2006.12.007
[8] MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases[J]. Dev Cell, 2009, 17(1): 9-26.  doi: 10.1016/j.devcel.2009.06.016
[9] Koehler A, Schlupf J, Schneider M, et al. Loss of Xenopus cadherin-11 leads to increased Wnt/beta-catenin signaling and up-regulation of target genes c-myc and cyclin D1 in neural crest[J]. Dev Biol, 2013, 383(1): 132-145.
[10] Königshoff M, Kramer M, Balsara N, et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis[J]. J Clin Invest, 2009, 119(4): 772-787.
[11]

Baker R, Kent CV, Silbermann RA, et al. Pea3 transcription factors and wnt1-induced mouse mammary neoplasia[J/OL]. PLoS One, 2010, 5(1): e8854[2013-09-05]. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0008854.
[12] Nusse R, Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the in the same regionof the host genome[J]. Cell, 1982, 31(1): 99-109.  doi: 10.1016/0092-8674(82)90409-3
[13] Ayyanan A, Civenni G, Ciarloni L, et al. Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism[J]. Proc Natl Acad Sci U S A, 2006, 103(10): 3799-3804.  doi: 10.1073/pnas.0600065103
[14] Ford CE, Ekström EJ, Andersson T. Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells[J]. Proc Natl Acad Sci U S A, 2009, 106(10): 3919-3924.  doi: 10.1073/pnas.0809516106
[15] Roarty K, Baxley SE, Crowley MR, et al. Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype[J]. Breast Cancer Res, 2009, 11(2): R19.  doi: 10.1186/bcr2244
[16] 周锐, 王平, 王建祥, 等. COX-2, VEGF和β-catenin表达及其与乳腺癌的相关性研究[J].临床外科杂志, 2009, 2(17): 122-124.
[17] Lin SY, Xia W, Wang JC, et al. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression[J]. Proc Natl Acad Sci U S A, 2000, 97(8): 4262-4266.  doi: 10.1073/pnas.060025397
[18] 李珊珊, 孙颖, 丁涣. β-catenin在不同亚型乳腺癌中的表达及其临床意义[J].山东大学学报:医学版, 2013, 51(3): 107-112.
[19] Lim SC, Lee MS. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer[J]. Oncol Rep, 2002, 9(5): 915-928.
[20] López-Knowles E, Zardawi SJ, McNeil CM, et al. Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients[J]. Cancer Epidemiol Biomarkers Prev, 2010, 19(1): 301-309.
[21] 何艳姣, 刘朝霞, 乔超, 等. Wnt信号通路在乳腺癌中的作用[J].山西医科大学学报, 2010, 41(3): 210-213, 284.  doi: 10.3969/j.issn.1007-6611.2010.03.007
[22] Ozaki S, Ikeda S, Ishizaki Y, et al. Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer[J]. Oncol Rep, 2005, 14(6): 1437-1443.
[23] Bala S, Peltomäki P. CYCLIN D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer[J]. Cancer Res, 2001, 61(16): 6042-6045.
[24] Dang CV. c-myc oncoprotein function[J]. Biochim Biophys Acta, 1991, 1072(2-3): 103-113.
[25] Krishna R, Mayer LD. Multidrug resistance(MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs[J]. Eur J Pharm Sci, 2000, 11(4): 265-283.  doi: 10.1016/S0928-0987(00)00114-7
[26] Trock BJ, Leonessa F, Clarke R. Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance[J]. J Natl Cancer Inst, 1997, 89(13): 917-931.  doi: 10.1093/jnci/89.13.917
[27] Haber M, Bordow SB, Haber PS, et al. The prognostic value of MDR1 gene expression in primary untreated neuroblastoma[J]. Eur J Cancer, 1997, 33(12): 2031-2036.  doi: 10.1016/S0959-8049(97)00229-3
[28] Kimura Y, Morita SY, Matsuo M, et al. Mechanism of multidrug recognition by MDR1/ABCB1[J]. Cancer Sci, 2007, 98(9): 1303-1310.  doi: 10.1111/j.1349-7006.2007.00538.x
[29] Yamada T, Takaoka AS, Naishiro Y, et al. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis[J]. Cancer Res, 2000, 60(17): 4761-4766.
[30] Milovanovic T, Planutis K, Nguyen A, et al. Expression of Wnt genes and frizzled 1 and 2 receptors in normal breast epithelium and infiltrating breast carcinoma[J]. Int J Oncol, 2004, 25(5): 1337-1342.
[31] Zhang H, Zhang X, Wu X, et al. Interference of Frizzled 1(FZD1)reverses multidrug resistance in breast cancer cells through the Wnt/β-catenin pathway[J]. Cancer Lett, 2012, 323(1): 106-113.  doi: 10.1016/j.canlet.2012.03.039
[32] Zhang M, Atkinson RL, Rosen JM. Selective targeting of radiation-resistant tumor-initiating cells[J]. Proc Natl Acad Sci U S A, 2010, 107(8): 3522-3527.  doi: 10.1073/pnas.0910179107
[33] Chen MS, Woodward WA, Behbod F, et al. Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line[J]. J Cell Sci, 2007, 120(Pt 3): 468-477.
[34] Woodward WA, Chen MS, Behbod F, et al. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells[J]. Proc Natl Acad Sci U S A, 2007, 104(2): 618-623.  doi: 10.1073/pnas.0606599104
[35] Cantley LC. The phosphoinositide 3-kinase pathway[J]. Science, 2002, 296(5573): 1655-1657.  doi: 10.1126/science.296.5573.1655
[36] Fukumoto S, Hsieh CM, Maemura K, et al. Akt participation in the Wnt signaling pathway through Dishevelled[J]. J Biol Chem, 2001, 276(20): 17479-17483.  doi: 10.1074/jbc.C000880200
[37] Zhu HX, Zhang G, Wang YH, et al. Indomethacin induces apoptosis through inhibition of survivin regulated by beta-catenin/TCF4 in human colorectal cancer cells[J]. Ai Zheng, 2004, 23(7): 737-741.
[38] Kim Y, Kim KH, Lee J, et al. Wnt activation is implicated in glioblastoma radioresistance[J]. Lab Invest, 2012, 92(3): 466-473.  doi: 10.1038/labinvest.2011.161
[39] Qi J, Zhu YQ. Targeting the most upstream site of Wnt signaling pathway provides a strategic advantage for therapy in colorectal cancer[J]. Curr Drug Targets, 2008, 9(7): 548-557.  doi: 10.2174/138945008784911769